Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers

Jordi Heijman; Ann-Kathrin Rahm; Dobromir Dobrev

doi:10.1016/j.ijcha.2021.100924

Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers

Jordi Heijman^*, Ann-Kathrin Rahm, Dobromir Dobrev

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	100924
Number of pages	3
Journal	IJC Heart and Vasculature
Volume	37
DOIs	https://doi.org/10.1016/j.ijcha.2021.100924
Publication status	Published - Dec 2021

Keywords

ATRIAL
FIBRILLATION

Access to Document

10.1016/j.ijcha.2021.100924Licence: CC BY-NC-ND

Cite this

@article{6c262678e9564b74908dacb14bedc0db,

title = "Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers",

keywords = "ATRIAL, FIBRILLATION",

author = "Jordi Heijman and Ann-Kathrin Rahm and Dobromir Dobrev",

note = "Funding Information: Netherlands Organization for Scientific Research NWO/ZonMW Vidi 09150171910029 to J.H.), Heidelberg University Medical Faculty (Olympia Morata Program) to A-K.R, National Institutes of Health (R01HL136389, R01HL131517, and R01HL089598 to D.D.), the German Research Foundation (DFG, Do 769/4-1 to D.D.), and the European Union (large-scale integrative project MAESTRIA, No. 965286 to D.D.). Funding Information: Netherlands Organization for Scientific Research NWO/ZonMW Vidi 09150171910029 to J.H.), Heidelberg University Medical Faculty (Olympia Morata Program) to A-K.R, National Institutes of Health ( R01HL136389 , R01HL131517 , and R01HL089598 to D.D.), the German Research Foundation (DFG, Do 769/4-1 to D.D.), and the European Union (large-scale integrative project MAESTRIA, No. 965286 to D.D.). ",

year = "2021",

month = dec,

doi = "10.1016/j.ijcha.2021.100924",

language = "English",

volume = "37",

journal = "IJC Heart and Vasculature",

issn = "2352-9067",

publisher = "Elsevier",

}

TY - JOUR

T1 - Stretching the limits of antiarrhythmic drug therapy

T2 - The promise of small-conductance calcium-activated potassium channel blockers

AU - Heijman, Jordi

AU - Rahm, Ann-Kathrin

AU - Dobrev, Dobromir

N1 - Funding Information: Netherlands Organization for Scientific Research NWO/ZonMW Vidi 09150171910029 to J.H.), Heidelberg University Medical Faculty (Olympia Morata Program) to A-K.R, National Institutes of Health (R01HL136389, R01HL131517, and R01HL089598 to D.D.), the German Research Foundation (DFG, Do 769/4-1 to D.D.), and the European Union (large-scale integrative project MAESTRIA, No. 965286 to D.D.). Funding Information: Netherlands Organization for Scientific Research NWO/ZonMW Vidi 09150171910029 to J.H.), Heidelberg University Medical Faculty (Olympia Morata Program) to A-K.R, National Institutes of Health ( R01HL136389 , R01HL131517 , and R01HL089598 to D.D.), the German Research Foundation (DFG, Do 769/4-1 to D.D.), and the European Union (large-scale integrative project MAESTRIA, No. 965286 to D.D.).

PY - 2021/12

Y1 - 2021/12

KW - ATRIAL

KW - FIBRILLATION

U2 - 10.1016/j.ijcha.2021.100924

DO - 10.1016/j.ijcha.2021.100924

M3 - Article

C2 - 34917752

SN - 2352-9067

VL - 37

JO - IJC Heart and Vasculature

JF - IJC Heart and Vasculature

M1 - 100924

ER -